��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Dose Dense One Week On/One Week Off Temozolomide in Recurrent Glioma

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 021

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Walter Taal, MD	No disclosure on file
Joyce Segers-Van Ryn, MD	No disclosure on file
	No disclosure on file
Eric J. Sorenson, MD, FAAN (Mayo Clinic)	The institution of Dr. Sorenson has received research support from Biogen.
	No disclosure on file
Jacoline Bromberg, MD	No disclosure on file
Peter Sillevis Smitt, MD (Erasmus MC)	The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Martin Van Den Bent	Martin Van Den Bent has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fore Biotherapeutics. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Cancer. Martin Van Den Bent has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuro-Oncology.